NCT07696442

Brief Summary

The goal of this clinical trial is to learn if a music-based intervention works to improve sleep and health in children with epilepsy and their parents. The main question it aims to answer is: Does the music-based intervention improve sleep and health for both the children and their parents?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
41mo left

Started Aug 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 10, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

July 14, 2026

Status Verified

June 1, 2026

Enrollment Period

3.3 years

First QC Date

July 6, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

Pediatric epilepsyMusicSleep

Outcome Measures

Primary Outcomes (1)

  • Sleep Efficiency

    Sleep efficiency, measured objectively using actigraphy, is a key indicator of sleep quality. It is calculated as the ratio of total nighttime sleep time to time in bed, multiplied by 100%.

    Baseline, 2 weeks, 3 months, and 6 months after randomization

Secondary Outcomes (8)

  • Total Nighttime Sleep

    Baseline, 2 weeks, 3 months, and 6 months after randomization

  • Daily 24-hour Sleep Duration

    Baseline, 2 weeks, 3 months, and 6 months after randomization

  • Sleep Onset Latency

    Baseline, 2 weeks, 3 months, and 6 months after randomization

  • Wake After Sleep Onset

    Baseline, 2 weeks, 3 months, and 6 months after randomization

  • Children's Sleep Habits Questionnaire (CSHQ)

    Baseline, 2 weeks, 3 months, and 6 months after randomization

  • +3 more secondary outcomes

Study Arms (2)

Experimental music intervention group

EXPERIMENTAL

Participants will listen to the experimental music module twice daily (before bedtime and upon waking) for 6 months.

Behavioral: Music-based intervention

Active control music group

PLACEBO COMPARATOR

Participants will listen to the control music module twice daily (before bedtime and upon waking) for 6 months.

Behavioral: Active Control Placebo

Interventions

Participants will listen to a standardized nighttime music piece within approximately 30 minutes before their habitual bedtime and a daytime intervention music piece upon waking each day for 6 months.

Experimental music intervention group

Participants will listen to a standardized nighttime music piece within approximately 30 minutes before their habitual bedtime and a daytime placebo music piece upon waking each day for 6 months.

Active control music group

Eligibility Criteria

Age18 Months - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 1.5 and 9 years with epilepsy;
  • Parents with sufficient Chinese language proficiency and skills to comprehend the study procedures and complete questionnaires.

You may not qualify if:

  • Children who have severe hearing loss even with the use of hearing devices;
  • Children who are bedridden;
  • Children with a documented sleep disorder, such as obstructive or central sleep apnea and sleep-related movement disorders;
  • Children with severe motor dysfunction that preclude differentiation of sleep and wake states via actigraphy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Shao-Yu Tsai, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2026

First Posted

July 10, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

July 14, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations